Matsuda Masaru (CIK 1798679) reported 23 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-18). Recent activity: Sell ARQT (3,674 shares), Sell ARQT (9,989 shares), Sell ARQT (1,230 shares), Sell ARQT (7,372 shares), Sell ARQT (884 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-18 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: EVP, Chief Legal Officer | Sell | 3,674 | $91,853 |
| 2026-09-10 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: EVP, Chief Legal Officer | Sell | 9,989 | $249,986 |
| 2026-08-05 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: EVP, Chief Legal Officer | Sell | 1,230 | $32,124 |
| 2026-05-06 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: EVP, Chief Legal Officer | Sell | 7,372 | $171,546 |
| 2026-05-06 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: EVP, Chief Legal Officer | Sell | 884 | $20,871 |
| 2026-03-03 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: EVP, Chief Legal Officer | Buy | 37,000 | $0 |
| 2026-03-03 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: EVP, Chief Legal Officer | Sell | 3,325 | $92,934 |
| 2026-03-03 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: EVP, Chief Legal Officer | Sell | 6,553 | $164,873 |
| 2026-03-03 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: EVP, Chief Legal Officer | Sell | 193 | $5,001 |
| 2026-03-03 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: EVP, Chief Legal Officer | Sell | 1,987 | $51,066 |
| 2026-02-04 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: SVP General Counsel and Corporate Secretary | Sell | 7,983 | $203,566 |
| 2026-02-04 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: SVP General Counsel and Corporate Secretary | Sell | 8,562 | $213,793 |
| 2026-02-04 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: SVP General Counsel and Corporate Secretary | Sell | 19,379 | $489,126 |
| 2026-02-04 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: SVP General Counsel and Corporate Secretary | Sell | 4,714 | $120,820 |
| 2025-12-03 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: SVP General Counsel and Corporate Secretary | Sell | 1,657 | $50,091 |
| 2025-11-21 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: SVP General Counsel and Corporate Secretary | Sell | 989 | $27,643 |
| 2025-11-21 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: SVP General Counsel and Corporate Secretary | Sell | 1,561 | $44,488 |
| 2025-11-05 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: SVP General Counsel and Corporate Secretary | Sell | 7,165 | $177,047 |
| 2025-11-05 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: SVP General Counsel and Corporate Secretary | Sell | 43 | $1,092 |
| 2025-09-08 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: SVP General Counsel and Corporate Secretary | Sell | 36,130 | $583,861 |
| 2025-08-05 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: SVP General Counsel and Corporate Secretary | Sell | 6,330 | $90,709 |
| 2025-05-29 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: SVP General Counsel and Corporate Secretary | Sell | 1,800 | $24,804 |
| 2025-05-05 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: SVP General Counsel and Corporate Secretary | Sell | 5,030 | $76,456 |
来源：SEC Form 4 申报文件 · 截至 2026-09-18